Turkson J - Search Results

1

STAT proteins: novel molecular targets for cancer drug discovery.

Turkson J, Jove R. Turkson J, et al. Oncogene. 2000 Dec 27;19(56):6613-26. doi: 10.1038/sj.onc.1204086. Oncogene. 2000. PMID: 11426647 Review.

2

Therapeutic modulators of STAT signalling for human diseases.

Miklossy G, Hilliard TS, Turkson J. Miklossy G, et al. Among authors: turkson j. Nat Rev Drug Discov. 2013 Aug;12(8):611-29. doi: 10.1038/nrd4088. Nat Rev Drug Discov. 2013. PMID: 23903221 Free PMC article. Review.

3

Ligand-independent phosphorylation of Y869 (Y845) links mutant EGFR signaling to stat-mediated gene expression.

Yang S, Park K, Turkson J, Arteaga CL. Yang S, et al. Among authors: turkson j. Exp Cell Res. 2008 Jan 15;314(2):413-9. doi: 10.1016/j.yexcr.2007.09.002. Epub 2007 Sep 8. Exp Cell Res. 2008. PMID: 17927978 Free PMC article.

4

Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells.

Vultur A, Cao J, Arulanandam R, Turkson J, Jove R, Greer P, Craig A, Elliott B, Raptis L. Vultur A, et al. Among authors: turkson j. Oncogene. 2004 Apr 8;23(15):2600-16. doi: 10.1038/sj.onc.1207378. Oncogene. 2004. PMID: 15007380

5

STAT3 activation by type I interferons is dependent on specific tyrosines located in the cytoplasmic domain of interferon receptor chain 2c. Activation of multiple STATS proceeds through the redundant usage of two tyrosine residues.

Velichko S, Wagner TC, Turkson J, Jove R, Croze E. Velichko S, et al. Among authors: turkson j. J Biol Chem. 2002 Sep 20;277(38):35635-41. doi: 10.1074/jbc.M204578200. Epub 2002 Jun 24. J Biol Chem. 2002. PMID: 12105218

6

Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.

Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H. Niu G, et al. Among authors: turkson j. Oncogene. 2002 Mar 27;21(13):2000-8. doi: 10.1038/sj.onc.1205260. Oncogene. 2002. PMID: 11960372

7

Targeting STAT3 in cancer: how successful are we?

Yue P, Turkson J. Yue P, et al. Among authors: turkson j. Expert Opin Investig Drugs. 2009 Jan;18(1):45-56. doi: 10.1517/13543780802565791. Expert Opin Investig Drugs. 2009. PMID: 19053881 Free PMC article. Review.

8

Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein.

Kotha A, Sekharam M, Cilenti L, Siddiquee K, Khaled A, Zervos AS, Carter B, Turkson J, Jove R. Kotha A, et al. Among authors: turkson j. Mol Cancer Ther. 2006 Mar;5(3):621-9. doi: 10.1158/1535-7163.MCT-05-0268. Mol Cancer Ther. 2006. PMID: 16546976

9

Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.

Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R. Gritsko T, et al. Among authors: turkson j. Clin Cancer Res. 2006 Jan 1;12(1):11-9. doi: 10.1158/1078-0432.CCR-04-1752. Clin Cancer Res. 2006. PMID: 16397018

10

Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer.

Haura EB, Turkson J, Jove R. Haura EB, et al. Among authors: turkson j. Nat Clin Pract Oncol. 2005 Jun;2(6):315-24. doi: 10.1038/ncponc0195. Nat Clin Pract Oncol. 2005. PMID: 16264989 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results